Need Help? Call 1­-866-­796-­7386
« back to stock screener

  NKTR stock: Nektar Therapeutics

Current Rating
Strong Sell

Previous Rating

Strong Sell
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$49.75
Market Cap
3.7B
Sector
Health Care
Div. Growth
-
P/E
-
P/B
-
P/S
27.56
Dividend %
-
P/CF
-
P/FCF
-
Op. Cash Flow
-172.9K
FCF
-1.2
Op. Margin
-127.80%
Net Margin
-157.10%
ROE
-
ROI
-33.80%
ROA
-41.90%
EPS Growth
-44.90%
Current Ratio
5.9
Debt/Equity
278.90%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Lannett Company, Inc. (LCI) $25.55 - - 842.6M Strong Buy
Community Health Systems (CYH) $4.17 - - 667.9M Strong Buy
Envision Healthcare Corp (EVHC) $30.06 - - 5.23B Strong Buy
CombiMatrix Corp (CBMX) $6.25 - - 21.2M Strong Buy
American Renal Associates Hold (ARA) $13.10 - - 396.4M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More